Latest

03.31.2021

OncoResponse Raises $40.6 Million Series C Financing

Read Article
02.15.2021

Targeting a Key Marker of Clotting and Inflammation in COVID-19 Patients

Read Article
11.24.2020

Targeting Calcium Overload Could Improve Stroke Outcomes

Read Article
10.29.2020

COVID-19 viral biotech Atea Pharmaceuticals prices upsized IPO at $24 high end

Read Article
Up NextAbout Us